U
Neuren Pharmaceuticals Limited NURPF
$10.97 -$1.31-10.67% OTC PK
Recommendation
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -2.75% 1,600.06% 0.20% -92.60% -0.47%
Total Depreciation and Amortization -2.70% 2.78% 0.00% 0.00% 0.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -2.75% 925.45% -0.21% -129.10% -0.47%
Change in Net Operating Assets 2.75% -396.70% -0.21% -203.18% -0.47%
Cash from Operations -2.75% 145.88% -0.21% -114.80% -0.47%
Capital Expenditure 0.00% -130.00% 0.00% 86.11% 0.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -2.75% 298.09% 0.22% 100.52% 0.47%
Cash from Investing -2.75% 298.70% 0.22% 100.52% 0.47%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% 0.00% -34.47% 0.00%
Repurchase of Common Stock 0.00% -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 100.00% 0.00% 18.18% 0.00%
Cash from Financing 2.75% -742.08% 0.20% -33.94% -0.47%
Foreign Exchange rate Adjustments 2.75% -144.81% 0.21% 1,021.10% -0.48%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -2.77% 104.08% -0.21% 31.18% 0.47%